Cargando…
Effect of intravenous ondansetron on QT interval prolongation in patients with cardiovascular disease and additional risk factors for torsades: a prospective, observational study
BACKGROUND: The 5-hydroxytryptamine type 3 antagonists, or setrons (eg, ondansetron), are commonly used for nausea and vomiting in the hospital setting. In 2001, droperidol was given a black box warning because it was found to prolong the QT interval and induce arrhythmias. The setrons share with dr...
Autores principales: | Hafermann, Matthew J, Namdar, Rocsanna, Seibold, Gretchen E, Page, Robert Lee |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3202761/ https://www.ncbi.nlm.nih.gov/pubmed/22046106 http://dx.doi.org/10.2147/DHPS.S25623 |
Ejemplares similares
-
Transient Acquired QT Interval Prolongation After Administration of Intravenous Ondansetron
por: Mao, Ruochen, et al.
Publicado: (2021) -
QT interval prolongation and Torsades de Pointes with donepezil, rivastigmine and galantamine
por: Malone, Katie, et al.
Publicado: (2020) -
Evaluation of Ondansetron-induced QT interval prolongation in the prophylaxis of postoperative emesis
por: Gupta, Sampa Dutta, et al.
Publicado: (2011) -
Chloroquine/erythromycin: QT interval prolongation and Torsade de Pointes: case report
Publicado: (2020) -
DOTHIEPIN, QT PROLONGATION AND TORSADES DE POINTES
por: Andrade, Chittaranjan, et al.
Publicado: (1999)